BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1869011)

  • 1. [Adjuvant chemotherapy in dysgerminoma].
    Fechtig A; de Dycker RP; Schumacher T; Neumann RL
    Geburtshilfe Frauenheilkd; 1991 May; 51(5):398-400. PubMed ID: 1869011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of ovarian germ cell tumors.
    Williams SD
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful pregnancy after conservative surgery and chemotherapy for dysgerminoma of the ovary: case report].
    Studziński Z; Kaliński S; Filipczak A; Branicka D
    Ginekol Pol; 1999 Aug; 70(8):553-7. PubMed ID: 10534934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Hatch KD; Homesley HD
    J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carboplatin/epirubicin/prednimustine (Sterecyt) as an adjuvant chemotherapy combination in ovarian cancer treated by radical surgery].
    Pickel H
    Gynakol Rundsch; 1989; 29 Suppl 2():357-8. PubMed ID: 2693256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dysgerminomas. Clinical aspects, therapy and prognosis with reference to the cooperative therapy study MAIKEI 83/86 for non-testicular germ cell tumors of the Society of Pediatric Oncology].
    Göbel U; Bamberg M; Calaminus G; Jürgens H; Pelzer V; Simon WE; Terruhn V; Wolf A; Mecke H; Harms D
    Geburtshilfe Frauenheilkd; 1989 Aug; 49(8):737-42. PubMed ID: 2792708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed germ cell tumors of the ovary.
    Gershenson DM; Del Junco G; Copeland LJ; Rutledge FN
    Obstet Gynecol; 1984 Aug; 64(2):200-6. PubMed ID: 6204258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
    Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
    Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
    Jeyakumar A; Cabeza R; Hindenburg A
    Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].
    Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of malignant germ cell tumors of the ovary: a clinical analysis of 233 cases].
    Zhang R; Hong W; Liu L
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):155-7. PubMed ID: 10920972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian dysgerminoma associated with fibrosarcoma: a case report.
    Alvarado-Cabrero I; Valencia-Cedillo R; Mohs-Alfaro M; De Anda-González J
    Int J Gynecol Pathol; 2011 Sep; 30(5):466-9. PubMed ID: 21804387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A carcinosarcoma of the ovary: a case report and a review].
    Ishihara H; Kanamori Y; Morishita K; Minagawa Y; Kigawa J; Matsui K
    Gan No Rinsho; 1990 Sep; 36(11):2105-9. PubMed ID: 2232179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pure ovarian dysgerminoma. Evaluation of experiences and definition of a therapeutic strategy].
    Dilhuydy JM; Lagarde P; Chauvergne J; Mongodin B; Dilhuydy MH; Coindre JM; Avril A; Richaud P; Pigneux J
    Bull Cancer; 1990; 77(3):213-24. PubMed ID: 2340352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysgerminoma of the ovary.
    LaPolla JP; Benda J; Vigliotti AP; Anderson B
    Obstet Gynecol; 1987 Jun; 69(6):859-64. PubMed ID: 3574816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dysgerminoma of the ovary. Presentation of case report].
    Mihaylova I; Parvanova V; Kostova P
    Akush Ginekol (Sofiia); 2013; 52(2):56-9. PubMed ID: 23807982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
    Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
    Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of dysgerminoma].
    Brökelmann J; Hartlapp JH
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):282-4. PubMed ID: 3596209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.